Accéder au contenu
Merck

BDNF is required for seizure-induced but not developmental up-regulation of KCC2 in the neonatal hippocampus.

Neuropharmacology (2014-09-18)
Martin Puskarjov, Faraz Ahmad, Stanislav Khirug, Sudhir Sivakumaran, Kai Kaila, Peter Blaesse
RÉSUMÉ

A robust increase in the functional expression of the neuronal K-Cl cotransporter KCC2 during CNS development is necessary for the emergence of hyperpolarizing ionotropic GABAergic transmission. BDNF-TrkB signaling has been implicated in the developmental up-regulation of KCC2 and, in mature animals, in fast activity-dependent down-regulation of KCC2 function following seizures and trauma. In contrast to the decrease in KCC2 expression observed in the adult hippocampus following trauma, seizures in the neonate trigger a TrkB-dependent up-regulation of neuronal Cl(-) extrusion capacity associated with enhanced surface expression of KCC2. Here, we show that this effect is transient, and impaired in the hippocampus of Bdnf(-/-) mice. Notably, however, a complete absence of BDNF does not compromise the increase in KCC2 protein or K-Cl transport functionality during neuronal development. Furthermore, we present data indicating that the functional up-regulation of KCC2 by neonatal seizures is temporally limited by calpain activity.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Acide (Aminométhyl)phosphonique, 99%
Sigma-Aldrich
Bumetanide, ≥98%
Sigma-Aldrich
CNQX, ≥98% (HPLC), solid
Supelco
Acide (Aminométhyl)phosphonique, PESTANAL®, analytical standard
Bumetanide, European Pharmacopoeia (EP) Reference Standard